Neuro-Oncology Reviews




Volume 22 Number 3
15 February 2020




Home > Publications > Neuro-Oncology Reviews > Volume 22, Year 2020 > Number 3, 15 February






Xie Y, Lu Q, Lenahan C, Yang S, Zhou D, Qi X.
Whether statin use improves the survival of patients with glioblastoma?: A meta-analysis.
Medicine (Baltimore). 2020 Feb;99(9):e18997. doi: 10.1097/MD.0000000000018997. PMID: 32118710. Meta-analysis. ˍ




Armstrong TS, Dirven L, Arons D, Bates A, Chang SM, Coens C, Espinasse C, Gilbert MR, Jenkinson D, Kluetz P, Mendoza T, Rubinstein L, Sul J, Weller M, Wen PY, van den Bent MJ, Taphoorn MJB.
Glioma patient-reported outcome assessment in clinical care and research: a Response Assessment in Neuro-Oncology collaborative report.
Lancet Oncol. 2020 Feb 1;21(2):e97-e103. doi: 10.1016/S1470-2045(19)30796-X. PMID: 32007210. Review. ˍ




Azad TD, Duffau H.
Limitations of functional neuroimaging for patient selection and surgical planning in glioma surgery.
Neurosurg Focus. 2020 Feb 1;48(2):E12. doi: 10.3171/2019.11.FOCUS19769. PMID: 32006948. Review. ˍ




Stopa BM, Senders JT, Broekman MLD, Vangel M, Golby AJ.
Preoperative functional MRI use in neurooncology patients: a clinician survey.
Neurosurg Focus. 2020 Feb 1;48(2):E11. doi: 10.3171/2019.11.FOCUS19779. PMID: 32006949. Survey. ˍ



*

Bergqvist C, Servy A, Valeyrie-Allanore L, Ferkal S, Combemale P, Wolkenstein P; NF France Network.
Neurofibromatosis 1 French national guidelines based on an extensive literature review since 1966.
Orphanet J Rare Dis. 2020 Feb 3;15(1):37. doi: 10.1186/s13023-020-1310-3. PMID: 32014052. Guidelines. ˍ




Lu VM, Welby JP, Nesvick CL, Daniels DJ.
Efficacy and safety of bevacizumab in progressive pediatric low-grade glioma: a systematic review and meta-analysis of outcome rates.
Neurooncol Pract. 2020 Feb 3;7(4):359-368. doi: 10.1093/nop/npz076 PMID: 33282324. Review, Meta-analysis. ˍ




Prager BC, Bhargava S, Mahadev V, Hubert CG, Rich JN.
Glioblastoma Stem Cells: Driving Resilience through Chaos.
Trends Cancer. 2020 Feb 3;6(3):223-235. doi: 10.1016/j.trecan.2020.01.009. PMID: 32101725. Review. ˍ




Pombo Antunes AR, Scheyltjens I, Duerinck J, Neyns B, Movahedi K, Van Ginderachter JA.
Understanding the glioblastoma immune microenvironment as basis for the development of new immunotherapeutic strategies.
Elife. 2020 Feb 4;9:e52176. doi: 10.7554/eLife.52176. PMID: 32014107. Review. ˍ




Tejada S, Aquilina K, Goodden J, Pettorini B, Mallucci C, van Veelen ML, Thomale UW.
Biopsy in diffuse pontine gliomas: expert neurosurgeon opinion-a survey from the SIOPE brain tumor group.
Childs Nerv Syst. 2020 Feb 4;36(4):705-711. doi: 10.1007/s00381-020-04523-8. PMID: 32020269. Survey. ˍ




Ritchey AK et al., PDQ Pediatric Treatment Editorial Board.
Childhood Central Nervous System Germ Cell Tumors Treatment (PDQ®): Patient Version.
PDQ Cancer Inf Summ. 2020 Feb 5
. NCBI Bookshelf ID: NBK84259. PMID: 26389502. Review. ˍ




Cohen KJ, Constine LS, Packer RJ, Smith MA.
Childhood Medulloblastoma and Other Central Nervous System Embryonal Tumors Treatment (PDQ®): Health Professional Version.
PDQ Cancer Inf Summ. 2020 Feb 6. NCBI Bookshelf ID: NBK65981. PMID: 26389418. Review. ˍ




Hossain JA, Marchini A, Fehse B, Bjerkvig R, Miletic H.
Suicide gene therapy for the treatment of high-grade glioma: past lessons, present trends, and future prospects.
Neurooncol Adv. 2020 Feb 6;2(1):vdaa013. doi: 10.1093/noajnl/vdaa013. PMID: 32642680. Review. ˍ




Nejo T, Yamamichi A, Almeida ND, Goretsky YE, Okada H.
Tumor antigens in glioma.
Semin Immunol. 2020 Feb 6;47:101385. doi: 10.1016/j.smim.2020.101385. PMID: 32037183. Review. ˍ




Wierzbicki K, Ravi K, Franson A, Bruzek A, Cantor E, Harris M, Homan MJ, Marini BL, Kawakibi AR, Ravindran R, Teodoro R, Yadav V, Koschmann C.
Targeting and Therapeutic Monitoring of H3K27M-Mutant Glioma.
Curr Oncol Rep. 2020 Feb 6;22(2):19. doi: 10.1007/s11912-020-0877-0. PMID: 32030483. Review. ˍ




Bahmad HF, Poppiti RJ.
Medulloblastoma cancer stem cells: molecular signatures and therapeutic targets.
J Clin Pathol. 2020 Feb 7;73(5):243-249. doi: 10.1136/jclinpath-2019-206246. PMID: 32034059. Review. ˍ




Kluiver TA, Alieva M, van Vuurden DG, Wehrens EJ, Rios AC.
Invaders Exposed: Understanding and Targeting Tumor Cell Invasion in Diffuse Intrinsic Pontine Glioma.
Front Oncol. 2020 Feb 7;10:92. doi: 10.3389/fonc.2020.00092. PMID: 32117746. Review. ˍ




Xu S, Tang L, Li X, Fan F, Liu Z.
Immunotherapy for glioma: Current management and future application.
Cancer Lett. 2020 Feb 7;476:1-12. doi: 10.1016/j.canlet.2020.02.002. PMID: 32044356. Review. ˍ



*

La Rocca G, Sabatino G, Menna G, Altieri R, Ius T, Marchese E, Olivi A, Barresi V, Della Pepa GM.
5-Aminolevulinic Acid False Positives in Cerebral Neuro-Oncology: Not All That Fluorescent Is Tumor. A Case-Based Update and Literature Review.
World Neurosurg. 2020 Feb 10;137:187-193. doi: 10.1016/j.wneu.2020.01.238. PMID: 32058110. Review. ˍ




Yang J, Shi Z, Liu R, Wu Y, Zhang X.
Combined-therapeutic strategies synergistically potentiate glioblastoma multiforme treatment via nanotechnology.
Theranostics. 2020 Feb 10;10(7):3223-3239. doi: 10.7150/thno.40298. PMID: 32194864. Review. ˍ




Birbrair A (ed).
Tumor Microenvironment. Non-Hematopoietic Cells.
Adv Exp Med Biol. 2020 Feb 11. doi: 10.1007/978-3-030-37184-5. Book. ˍ




Hide T, Komohara Y.
Oligodendrocyte Progenitor Cells in the Tumor Microenvironment.
Adv Exp Med Biol. 2020 Feb 11;1234:107-122. doi: 10.1007/978-3-030-37184-5_8. PMID: 32040858. Review. ˍ




Song D, Xu D, Gao Q, Hu P, Guo F.
Intracranial Metastases Originating From Pediatric Primary Spinal Cord Glioblastoma Multiforme: A Case Report and Literature Review.
Front Oncol. 2020 Feb 11;10:99. doi: 10.3389/fonc.2020.00099. PMID: 32117750. Case report, Review. ˍ



*

Kaufmann TJ, Smits M, Boxerman J, Huang R, Barboriak DP, Weller M, Chung C, Tsien C, Brown PD, Shankar L, Galanis E, Gerstner E, van den Bent MJ, Burns TC, Parney IF, Dunn G, Brastianos PK, Lin NU, Wen PY, Ellingson BM.
Consensus recommendations for a standardized brain tumor imaging protocol for clinical trials in brain metastases (BTIP-BM).
Neuro Oncol. 2020 Feb 12;22(6):757-772. doi: 10.1093/neuonc/noaa030. PMID: 32048719. Guidelines. ˍ



*

Pertz M, Popkirov S, Schlegel U, Thoma P.
Research on cognitive and sociocognitive functions in patients with brain tumours: a bibliometric analysis and visualization of the scientific landscape.
Neurol Sci. 2020 Feb 12;41(6):1437-1449. doi: 10.1007/s10072-020-04276-x. PMID: 32052308. Bibliometric analysis. ˍ




Mohme M, Neidert MC.
Tumor-Specific T Cell Activation in Malignant Brain Tumors.
Front Immunol. 2020 Feb 13;11:205. doi: 10.3389/fimmu.2020.00205. PMID: 32117316. Review. ˍ




Dirks PB, Gilbert MR, Holland EC, Maher EA, Weiss WA.
Translating basic science discoveries into improved outcomes for glioblastoma.
Clin Cancer Res. 2020 Feb 14;26(11):2457-2460. doi: 10.1158/1078-0432.CCR-19-3924. PMID: 32060102. Review. ˍ




Partridge B, Rossmeisl JH, Kaloss AM, Basso EKG, Theus MH.
Novel ablation methods for treatment of gliomas.
J Neurosci Methods. 2020 Feb 14. 2020;336:108630. doi: 10.1016/j.jneumeth.2020.108630. PMID: 32068011. Review. ˍ




Hodler J, Kubik-Huch RA, von Schulthess GK, editors.
Diseases of the Brain, Head and Neck, Spine 2020–2023: Diagnostic Imaging.
IDKD Springer Series. 2020 Feb 15. doi: 10.1007/978-3-030-38490-6. NCBI Bookshelf ID: NBK554343. PMID: 32119229. Book. ˍ ˍ




Smirniotopoulos JG, Jäger HR.
Differential Diagnosis of Intracranial Masses.
In: Hodler J, Kubik-Huch RA, von Schulthess GK, editors. Diseases of the Brain, Head and Neck, Spine 2020–2023. Chapter 8. Diagnostic Imaging.
Springer. 2020 Feb 15. doi: 10.1007/978-3-030-38490-6_8. NCBI Bookshelf ID: NBK554352. PMID: 32119256. Review. ˍ